Retraction
The safety profile of probiotic VSL#3®. A meta-analysis of safety data from double-blind, randomized, placebo-controlled clinical trials
Paper Information
Record ID:
34929
Author(s):
Publication Date:
January 30, 2021
Retraction Date:
December 30, 2021
(3.9 years years ago)
Subject:
Broad Categories:
Medicine
Medicine
Specific Fields:
Medicine - Pharmacology
Medicine - Pharmacology
Institutions:
- L’altrastatistica S.r.l., for GB Pharma Services & Consulting S.r.l, Rome, Italy
- Clinical Research & Development Consultants S.r.l., Sesto Fiorentino, Italy
- GB Pharma Services & Consulting S.r.l., Pavia, Italy
- Institute of Pharmacology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma – Università Cattolica del Sacro Cuore, Rome, Italy
Country:
🇮🇹 ItalyArticle Type:
Publisher:
Verduci Editore
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Not indexed in PubMed
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.26355/eurrev_202111_27130Additional Notes:
see also: https://pubpeer.com/publications/08BF4E5F8CCB4921BF4EB2F2CEB763
Citations (4)
4
Total Citations1
Post-Retraction(25.0%)
2
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
1
Within 1 year
0
After 2+ years
2
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Probiotic colonization dynamics after oral consumption of VSL#3® by antibiotic-treated mice
Casey M. Theriot, Rajani Thanissery, Sarah O’Flaherty et al. (4 authors)
Microbiome Research Reports
Open Access
Published: Jan 2022
4 citations
4 citations
2 days after retraction
The Probiotic VSL#3® Does Not Seem to Be Efficacious for the Treatment of Gastrointestinal Symptomatology of Patients with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Elena P. Calandre, Javier Hidalgo‐Tallon, Rocío Molina-Barea et al. (8 authors)
Pharmaceuticals
Open Access
Published: Oct 2021
6 citations
6 citations
72 days before retraction
Microbial Metabolites: Critical Regulators in NAFLD
Xin Dai, Huiqin Hou, Wanru Zhang et al. (8 authors)
Frontiers in Microbiology
Open Access
Published: Oct 2020
86 citations
86 citations
449 days before retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
3.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025